Case number 1:23-cv-00048
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Hetero USA Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 12, 2023 | 18 | CONSENT JUDGMENT Signed by Judge Colm F. Connolly on 10/12/2023. (nmf) (Entered: 10/12/2023) (4) |
| Oct 12, 2023 | 19 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,486,526 B2; 10,034,877 B2. (Attachments: # 1 Consent Judgment)(nmf) (Entered: 10/12/2023) (0) |
| Oct 11, 2023 | 17 | PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 10/11/2023) (4) |
| Oct 10, 2023 | 16 | REDACTED VERSION of 14 Status Report by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 10/10/2023) (2) |
| Oct 4, 2023 | 13 | STIPULATION and [Proposed] Order to File Under Seal - by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 10/04/2023) (2) |
| Oct 4, 2023 | 14 | [SEALED] Joint STATUS REPORT - by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 10/04/2023) (0) |
| Oct 4, 2023 | 15 | SO ORDERED, re 13 Stipulation to File Under Seal, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 10/4/2023. (kmd) (Entered: 10/04/2023) (2) |
| Sep 27, 2023 | 11 | NOTICE of Appearance by Kenneth Laurence Dorsney on behalf of Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. (Dorsney, Kenneth) (Entered: 09/27/2023) (1) |
| Sep 27, 2023 | 12 | NOTICE of Appearance by Cortlan S. Hitch on behalf of Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. (Hitch, Cortlan) (Entered: 09/27/2023) (1) |
| Feb 1, 2023 | 8 | WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH: For Hetero USA Inc. waiver sent on 2/1/2023, answer due 4/3/2023. (Dellinger, Megan) (Entered: 02/01/2023) (1) |
| Feb 1, 2023 | 9 | WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH: For Hetero Labs Limited waiver sent on 2/1/2023, answer due 4/3/2023. (Dellinger, Megan) (Entered: 02/01/2023) (1) |
| Feb 1, 2023 | 10 | WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH: For Hetero Labs Limited Unit-V waiver sent on 2/1/2023, answer due 4/3/2023. (Dellinger, Megan) (Entered: 02/01/2023) (1) |
| Jan 18, 2023 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 01/18/2023) (0) |
| Jan 18, 2023 | 7 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 01/18/2023) (2) |
| Jan 13, 2023 | 1 | COMPLAINT filed against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. ( Filing fee $ 402, receipt number ADEDC-4044243.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # 1 Exhibit 1-2, # 2 Civil Cover Sheet)(srs) (Entered: 01/17/2023) (Main Document) (13) |
| Jan 13, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) (Entered: 01/17/2023) (3) |
| Jan 13, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: December 5, 2022. Date of Expiration of Patent: August 5, 2029.Thirty Month Stay Deadline: 6/5/2025. (srs) (Entered: 01/17/2023) (1) |
| Jan 13, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,486,526 B2 ;10,034,877 B2. (srs) (Entered: 01/17/2023) (1) |
| Jan 13, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (srs) (Entered: 01/17/2023) (2) |
| Jan 13, 2023 | 6 | Summons Issued as to Hetero Labs Limited on 1/13/2023; Hetero Labs Limited Unit-V on 1/13/2023; Hetero USA Inc. on 1/13/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(srs) (Entered: 01/17/2023) (Main Document) (2) |
| Jan 13, 2023 | 1 | COMPLAINT filed against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. ( Filing fee $ 402, receipt number ADEDC-4044243.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # 1 Exhibit 1-2, # 2 Civil Cover Sheet)(srs) (Entered: 01/17/2023) (Exhibit 1-2) (30) |
| Jan 13, 2023 | 1 | COMPLAINT filed against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. ( Filing fee $ 402, receipt number ADEDC-4044243.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # 1 Exhibit 1-2, # 2 Civil Cover Sheet)(srs) (Entered: 01/17/2023) (Civil Cover Sheet) (2) |
| Jan 13, 2023 | 6 | Summons Issued as to Hetero Labs Limited on 1/13/2023; Hetero Labs Limited Unit-V on 1/13/2023; Hetero USA Inc. on 1/13/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(srs) (Entered: 01/17/2023) (Summons Issued) (2) |
| Jan 13, 2023 | 6 | Summons Issued as to Hetero Labs Limited on 1/13/2023; Hetero Labs Limited Unit-V on 1/13/2023; Hetero USA Inc. on 1/13/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(srs) (Entered: 01/17/2023) (Summons Issued) (2) |
